Results 221 to 230 of about 14,230 (249)

Second Correction for Shin et al., "Histone Deacetylase Classes I and II Regulate Kaposi's Sarcoma-Associated Herpesvirus Reactivation". [PDF]

J Virol
Shin HJ, DeCotiis J, Giron M, Palmeri D, Lukac DM.   +4 more
europepmc   +1 more source

タイ国におけるヒトヘルペスウイルス８の疫学的、病態的研究 [PDF]

Panasda, Isarangkura Na Ayuthaya, パナスダ, イスラングクラ, ナ アユタヤ   +1 more
core  

Some of the next articles are maybe not open access.

Related searches:

Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma

Microbes and Infection, 2000
Kaposi's sarcoma-associated herpesvirus (KSHV) is present in all epidemiologic forms of Kaposi's sarcoma (KS). The KSHV genome contains several open reading frames which are potentially implicated in the development of KS. Some are unique to KSHV; others are homologous to cellular genes.
H, Gruffat, A, Sergeant, E, Manet
openaire   +2 more sources

Kaposi's Sarcoma-Associated Herpesvirus

1998
Kaposi's sarcoma (KS) is a vascular tumor predominantly found in the immunosuppressed. Epidemiologic studies suggest that an infective agent is the etiologic culprit. Kaposi's sarcoma-associated herpesvirus (KSHV), or human herpesvirus-8 (HHV-8), is a gamma human herpesvirus present in all epidemiologic forms of KS and also in a rare type of a B cell ...
C, Boshoff, R A, Weiss
openaire   +2 more sources

Biology of Kaposi's sarcoma-associated herpesvirus

Frontiers in Bioscience, 2005
Kaposi's sarcoma-associated herpesvirus (KSHV) or human herpesvirus-8 (HHV-8) is a newly identified herpesvirus. KSHV is an important pathogen capable of causing disease that affects all age groups worldwide. KSHV is etiologically associated with all forms of Kaposi's sarcoma (KS), body cavity lymphomas, and multicentric Castleman disease (MCD).
Benjaman A, Bryan, Ossie F, Dyson, James A, McCubrey, Shaw M, Akula   +3 more
openaire   +2 more sources

Kaposi s sarcoma associated Herpesvirus immune evasion strategies

Frontiers in Bioscience, 2002
The battle between viruses and their hosts is beautiful in its complexity. The interplay between viral proteins and the immune system has taught researchers much about not just the virus, but also the molecular mechanisms underlying the immune response. With additional evasion strategies constantly being described, this avenue of research is still rich
Robert E, Means, Sabine M, Lang, Young-Hwa, Chung, Jae U, Jung   +3 more
openaire   +2 more sources

Kaposi-Sarcoma-Associated Herpesvirus

2008
Kaposi-sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 , is a member of the γ-herpesvirus family.
Blossom Damania, Dirk P. Dittmer
openaire   +1 more source

Kaposi's sarcoma‐associated herpesvirus and extracellular vesicles

Journal of Medical Virology, 2021
AbstractKaposi's sarcoma‐associated herpesvirus (KSHV) represents the etiological agent for several human malignancies, including Kaposi's Sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman's disease (MCD), which develop mainly in immunocompromised patients.
Lindsey Barrett, Lu Dai, Shanzhi Wang, Zhiqiang Qin   +3 more
openaire   +2 more sources

Kaposi Sarcoma–Associated Herpesvirus/Human Herpesvirus 8 and Kaposi Sarcoma

Advances in Dental Research, 2011
Kaposi sarcoma-associated herpesvirus (KSHV) was discovered in 1994 and is now known to be a necessary but not sufficient causative agent of Kaposi sarcoma. While KSHV is likely also the causative agent of primary effusion lymphoma and multicentric Castleman’s disease, its causal role has been refuted in the case of multiple myeloma, sarcoidosis ...
openaire   +2 more sources

Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis

Current Opinion in Virology, 2015
Kaposi Sarcoma-associated Herpesvirus (KSHV, HHV8) causes three human malignancies, Kaposi Sarcoma (KS), an endothelial tumor, as well as Primary Effusion Lymphoma (PEL) and the plasma cell variant of Multicentric Castleman's Disease (MCD), two B-cell lymphoproliferative diseases.
Thomas F, Schulz, Ethel, Cesarman
openaire   +2 more sources